CAS 151767-02-1

Acido ciclopropanoacetico, 1-[[[(1R)-1-[3-[(1E)-2-(7-cloro-2-chinolinil)etenil]fenil]-3-[2-(1-idrossi-1-metiletil)fenil]propil]tio]metil]-, sale di sodio (1:1)

Descrizione:

Acido ciclopropanoacetico, 1-[[[(1R)-1-[3-[(1E)-2-(7-cloro-2-chinolinil)etenil]fenil]-3-[2-(1-idrossi-1-metiletil)fenil]propil]tio]metil]-, sale di sodio (1:1) è un composto organico complesso caratterizzato dalle sue uniche caratteristiche strutturali, inclusi un anello di ciclopropano e vari gruppi funzionali che contribuiscono alla sua reattività chimica e attività biologica. Come sale di sodio, è probabile che mostri una maggiore solubilità in acqua rispetto alla sua forma acida, il che può migliorare la sua biodisponibilità nelle applicazioni farmaceutiche. La presenza di un gruppo quinolina suggerisce potenziali proprietà farmacologiche, possibilmente includendo attività antimicrobiche o antitumorali. Il legame tioetere del composto può anche influenzare la sua stabilità e reattività. La sua struttura intricata indica che potrebbe interagire con bersagli biologici in modo specifico, rendendolo di interesse nella chimica medicinale. In generale, questo composto esemplifica la complessità spesso trovata nelle molecole simili ai farmaci, combinando più gruppi funzionali che possono conferire diverse proprietà chimiche e biologiche.

Formula: C₃₅H₃₆ClNO₃S·Na

InChI: InChI=1S/C35H36ClNO3S.Na/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39);/b15-10+;/t32-;/m1./s1

InChI key: InChIKey=ZMFQNQCXWQXCFO-HKHDRNBDSA-N

SMILES: C(S[C@H](CCC1=C(C(C)(C)O)C=CC=C1)C2=CC(/C=C/C3=NC4=C(C=C3)C=CC(Cl)=C4)=CC=C2)C5(CC(O)=O)CC5.[Na]

Sinonimi:

• 1-[[[(R)-1-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid sodium salt
• 2-[1-[[1-[3-[2-[(7-Chloro-2-Quinolyl)]Vinyl]Phenyl]-3-[2-(1-Hydroxy-1-Methyl-Ethyl)Phenyl]-Propyl]Sulfanylmethyl]Cyclopropyl]Acetic Acid Sodium Salt
• 2-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropyl]acetic acid sodium salt
• Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, monosodium salt
• Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)
• Cyclopropaneacetic acid, 1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, monosodium salt, [R-(E)]-
• Kokast
• Methyl-[E]-(+)-1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)-ethenyl]phenyl]-3-[2-(1-hydroxyl-1-methylethyl)phenyl]propyl]mercapto]methyl]cyclopropane acetic acid sodium
• Mk-476
• Momazol
• Montair
• Montelukast Sodium Amorphous
• Montelukast monosodium salt
• Montikast
• Shantroz
• Singulair
• Sodium 2-[1-[[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetate
• Sodium montelukast
• sodium (1-{[(1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl)sulfanyl]methyl}cyclopropyl)acetate
• sodium {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetate
• sodium(R,E)-2-(1-(1-(3-(-(7-chloroqulnolln-2-yl)-3-(2-(2 hydroxypropan-2-yl)phenyl)propylthio)cyclopropyl)acetate

MONTELUKAST FOR PEAK IDENTIFICATION CRS

CAS: 151767-02-1

MONTELUKAST FOR PEAK IDENTIFICATION CRS

Formula: C₃₅H₃₅ClNNaO₃S

Peso molecolare: 608.1651

Ref: 41-Y0001435

MONTELUKAST SODIUM CRS

CAS: 151767-02-1

MONTELUKAST SODIUM CRS

Formula: C₃₅H₃₅ClNNaO₃S

Peso molecolare: 608.1651

Ref: 41-Y0001434

Montelukast Sodium

CAS: 151767-02-1

Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused

Formula: C₃₅H₃₅ClNO₃S·Na

Colore e forma: White Off-White Powder

Peso molecolare: 607.19239

Ref: 45-1446859

Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)

CAS: 151767-02-1

Formula: C₃₅H₃₅ClNNaO₃S

Purezza: 98%

Colore e forma: Solid

Peso molecolare: 608.1651

Ref: IN-DA003S60

Montelukast sodium

CAS: 151767-02-1

Montelukast sodium

Purezza: ≥98%

Peso molecolare: 608.17g/mol

Ref: 54-BUP15826

Montelukast sodium

CAS: 151767-02-1

Montelukast sodium

Purezza: 98%

Peso molecolare: 608.17g/mol

Ref: 54-OR1027179

Montelukast sodium salt

CAS: 151767-02-1

Formula: C₃₅H₃₅NO₃ClNaS

Purezza: ≥ 99.0%

Colore e forma: White to almost white powder or crystals

Peso molecolare: 608.17057

Ref: 7W-GX0261

Montelukast Sodium Salt

CAS: 151767-02-1

Formula: C₃₅H₃₅ClNO₃S·Na

Colore e forma: Pale Yellow Solid

Peso molecolare: 585.18 22.99

Ref: 4Z-M-301

Montelukast sodium

Prodotto controllato

CAS: 151767-02-1

Formula: C₃₅H₃₅ClNO₃S·Na

Colore e forma: Neat

Peso molecolare: 608.17

Ref: 04-C15319000

Montelukast Sodium

Prodotto controllato

CAS: 151767-02-1

Formula: C₃₅H₃₅ClNO₃S·Na

Colore e forma: Neat

Peso molecolare: 608.17

Ref: 86-MM0698.00

Montelukast sodium

CAS: 151767-02-1

Formula: C₃₅H₃₅ClNNaO₃S

Purezza: 98.0%

Peso molecolare: 608.17

Ref: 10-F547232

Montelukast Sodium

CAS: 151767-02-1, 158966-92-8

Formula: C₃₅H₃₅ClNNaO₃S

Purezza: >98.0%(T)(HPLC)

Colore e forma: White to Almost white powder to crystal

Peso molecolare: 608.17

Ref: 3B-M2340

Montelukast sodium

CAS: 151767-02-1

Montelukast sodium (MK0476), an oral leukotriene antagonist for asthma, can cause rare liver injury.

Formula: C₃₅H₃₅ClNNaO₃S

Purezza: 99.14% - 99.89%

Colore e forma: White To Off-White Crystalline Powder

Peso molecolare: 608.17

Ref: TM-T1677L

Montelukast Sodium for Identification RS

CAS: 151767-02-1

Colore e forma: White To Pale Yellow-White Solid Powder

Ref: 2K-1168430021

Montelukast Sodium

CAS: 151767-02-1

Formula: C₃₅H₃₅ClNO₃SNa

Peso molecolare: 585.18 : 23.0

Ref: ST-EA-CP-M25014

Montelukast Sodium Salt

Prodotto controllato

CAS: 151767-02-1

Applications A selective leukotriene D4-receptor antagonist. Used as an antiasthmatic.
References Labelle, M., et al.: Bioorg. Med. Chem. Lett., 5, 283 (1995), Jones, T.R., et al.: Can. J. Physiol. Pharmacol., 73, 191 (1995), Markham, A. and Faulds, D.: Drugs, 56, 251 (1998)

Formula: C₃₅H₃₅ClNO₃S·Na

Colore e forma: White To Light Yellow

Peso molecolare: 608.17

Ref: TR-M568000

Montelukast sodium salt - Bio-X ™

CAS: 151767-02-1

Montelukast is a leukotriene receptor antagonist that blocks the binding of leukotrienes to their receptors. It is used for the treatment of chronic cough, as well as for the relief of symptoms of seasonal and perennial allergic rhinitis. Montelukast binds to leukotriene receptors on cells in the airways, preventing them from attaching to leukotrienes and triggering an inflammatory response. This drug has been shown to be effective in controlling asthma symptoms by reducing bronchial hyperresponsiveness and relieving respiratory obstruction due to inflammation. Montelukast also has anti-inflammatory properties, which are thought to be due to its ability to inhibit production of pro-inflammatory cytokines such as IL-6.

Formula: C₃₅H₃₆ClNO₃S•Na

Purezza: Min. 95%

Colore e forma: Powder

Peso molecolare: 608.17 g/mol

Ref: 3D-BM164606

Montelukast sodium

CAS: 151767-02-1

Montelukast sodium is a leukotriene receptor antagonist that blocks the binding of leukotrienes to their receptors. It is used for the treatment of chronic cough, as well as for the relief of symptoms of seasonal and perennial allergic rhinitis. Montelukast sodium binds to leukotriene receptors on cells in the airways, preventing them from attaching to leukotrienes and triggering an inflammatory response. This drug has been shown to be effective in controlling asthma symptoms by reducing bronchial hyperresponsiveness and relieving respiratory obstruction due to inflammation. Montelukast sodium also has anti-inflammatory properties, which are thought to be due to its ability to inhibit production of pro-inflammatory cytokines such as IL-6.

Formula: C₃₅H₃₅ClNNaO₃S

Purezza: Min. 95%

Colore e forma: Powder

Peso molecolare: 608.17 g/mol

Ref: 3D-FM26073

Montelukast-d6 Sodium Salt

Prodotto controllato

CAS: 1093746-29-2, 151767-02-1, 158966-92-8

Formula: C₃₅H₂₉D₆ClNNaO₃S

Colore e forma: Neat

Peso molecolare: 614.2

Ref: TR-M568002